| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enanta Pharmaceuticals Inc (ENTA) has 8 insiders with recent SEC Form 4 filings, including 2 buys and 16 sells. ENTA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 858.0K | $13.16M | - | |
| Other | 371.4K | $5.70M | - | |
| Other | 38.3K | $588.0K | - | |
| Other | 30.6K | $469.7K | - | |
| Other | 21.8K | $334.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2016 | Or Yat Sun59 | Chief Scientific Officer | Sell | 13,921 | $31.44 | $437,609.42 | -4.2% | |
| May 11, 2016 | Gardiner Nathaniel S. | Sr. VP &General Counsel | Buy | 500 | $24.45 | $12,222.50 | +35.7% | |
| Feb 12, 2016 | Vance Terry | Director | Buy | 2,000 | $27.04 | $54,080.00 | +15.0% | |
| Nov 24, 2015 | Mellett Paul J63 | Treasurer And CFO | Sell | 6,000 | $30.15 | $180,921.71 | -3.5% | |
| Oct 15, 2015 | Mellett Paul J63 | Treasurer And CFO | Sell | 7,500 | $40.10 | $300,742.50 | -11.0% | |
| Sep 8, 2015 | Mellett Paul J63 | Treasurer And CFO | Sell | 7,500 | $39.55 | $296,653.06 | -5.2% | |
| Aug 10, 2015 | Or Yat Sun59 | Chief Scientific Officer | Sell | 3,750 | $42.90 | $160,883.51 | -0.9% | |
| Aug 7, 2015 | Mellett Paul J63 | Treasurer And CFO | Sell | 7,500 | $42.85 | $321,389.21 | -3.2% | |
| Jul 13, 2015 | Mellett Paul J63 | Treasurer And CFO | Sell | 7,500 | $46.29 | $347,206.66 | -4.3% | |
| Jul 13, 2015 | Or Yat Sun59 | Chief Scientific Officer | Sell | 3,750 | $46.29 | $173,594.50 | -0.9% |